Literature DB >> 19892214

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors.

Amy M Kilbourne1, Nancy E Morden, Karen Austin, Mark Ilgen, John F McCarthy, Gregory Dalack, Frederic C Blow.   

Abstract

OBJECTIVE: People with mental disorders are estimated to die 25 years younger than the general population, and heart disease (HD) is a major contributor to their mortality. We assessed whether Veterans Affairs (VA) health system patients with mental disorders were more likely to die from HD than patients without these disorders, and whether modifiable factors may explain differential mortality risks.
METHODS: Subjects included VA patients who completed the 1999 Large Health Survey of Veteran Enrollees (LHSV) and were either diagnosed with schizophrenia, bipolar disorder, other psychotic disorders, major depressive disorder or other depression diagnosis or diagnosed with none of these disorders. LHSV data on patient sociodemographic, clinical and behavioral factors (e.g., physical activity, smoking) were linked to mortality data from the National Death Index of the Centers for Disease Control and Prevention. Hierarchical multivariable Cox proportional hazards models were used to assess 8-year HD-related mortality risk by diagnosis, adding patient sociodemographic, clinical and behavioral factors.
RESULTS: Of 147,193 respondents, 11,809 (8%) died from HD. After controlling for sociodemographic and clinical factors, we found that those with schizophrenia [hazard ratio (HR)=1.25; 95% confidence interval (95% CI): 1.15-1.36; P<.001] or other psychotic disorders (HR=1.41; 95% CI: 1.27-1.55; P<.001) were more likely to die from HD than those without mental disorders. Controlling for behavioral factors diminished, but did not eliminate, the impact of psychosis on mortality. Smoking (HR=1.32; 95% CI: 1.26-1.39; P<.001) and inadequate physical activity (HR=1.66; 95% CI: 1.59-1.74; P<.001) were also associated with HD-related mortality.
CONCLUSIONS: Patients with psychosis were more likely to die from HD. For reduction of HD-related mortality, early interventions that promote smoking cessation and physical activity among veterans with psychotic disorders are warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19892214      PMCID: PMC4033835          DOI: 10.1016/j.genhosppsych.2009.07.008

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  32 in total

Review 1.  Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.

Authors:  Daniel E Casey; Dan W Haupt; John W Newcomer; David C Henderson; Michael J Sernyak; Michael Davidson; Jean-Pierre Lindenmayer; Steven V Manoukian; Mary Ann Banerji; Harold E Lebovitz; Charles H Hennekens
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

2.  Measurement strategies designed and tested in the Veterans Health Study.

Authors:  Katherine M Skinner; Donald R Miller; Avron Spiro; Lewis E Kazis
Journal:  J Ambul Care Manage       Date:  2004 Apr-Jun

Review 3.  Consensus development conference on antipsychotic drugs and obesity and diabetes.

Authors: 
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

4.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

5.  Three questions can detect hazardous drinkers.

Authors:  A J Gordon; S A Maisto; M McNeil; K L Kraemer; R L Conigliaro; M E Kelley; J Conigliaro
Journal:  J Fam Pract       Date:  2001-04       Impact factor: 0.493

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 7.  Excess mortality of mental disorder.

Authors:  E C Harris; B Barraclough
Journal:  Br J Psychiatry       Date:  1998-07       Impact factor: 9.319

8.  Comorbidity assessments based on patient report: results from the Veterans Health Study.

Authors:  Alfredo J Selim; Graeme Fincke; Xinhua S Ren; Austin Lee; William H Rogers; Donald R Miller; Katherine M Skinner; Mark Linzer; Lewis E Kazis
Journal:  J Ambul Care Manage       Date:  2004 Jul-Sep

9.  Cost of lost productive work time among US workers with depression.

Authors:  Walter F Stewart; Judith A Ricci; Elsbeth Chee; Steven R Hahn; David Morganstein
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts.

Authors:  Marcia Valenstein; Hyungjin Myra Kim; Dara Ganoczy; John F McCarthy; Kara Zivin; Karen L Austin; Katherine Hoggatt; Daniel Eisenberg; John D Piette; Frederic C Blow; Mark Olfson
Journal:  J Affect Disord       Date:  2008-10-22       Impact factor: 4.839

View more
  77 in total

1.  Serious mental illness and acute hospital readmission in diabetic patients.

Authors:  Jennifer S Albrecht; Jon Mark Hirshon; Richard Goldberg; Patricia Langenberg; Hannah R Day; Daniel J Morgan; Angela C Comer; Anthony D Harris; Jon P Furuno
Journal:  Am J Med Qual       Date:  2012-04-26       Impact factor: 1.852

2.  Evaluation of left ventricular systolic and diastolic functions in bipolar patients during lithium therapy.

Authors:  Cemil Zencir; Filiz A Ozdemiroglu; Mustafa Cetin; Sibel N Avcil; Mithat Selvi; Hasan Gungor; Cagdas Akgullu; Ebru Findikli; Gurkan Acar
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Gender differences in antipsychotics prescribed to veterans with serious mental illness.

Authors:  Elana Schwartz; Melanie Charlotte; Eric Slade; Deborah Medoff; Lan Li; Lisa Dixon; Amy Kilbourne; Julie Kreyenbuhl
Journal:  Gen Hosp Psychiatry       Date:  2015-04-01       Impact factor: 3.238

4.  Comorbidity profile and healthcare utilization in elderly patients with serious mental illnesses.

Authors:  Hugh C Hendrie; Donald Lindgren; Donald P Hay; Kathleen A Lane; Sujuan Gao; Christianna Purnell; Stephanie Munger; Faye Smith; Jeanne Dickens; Malaz A Boustani; Christopher M Callahan
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  Survival among Veterans Obtaining Dialysis in VA and Non-VA Settings.

Authors:  Virginia Wang; Cynthia J Coffman; Karen M Stechuchak; Theodore S Z Berkowitz; Paul L Hebert; David Edelman; Ann M O'Hare; Susan T Crowley; Hollis J Weidenbacher; Matthew L Maciejewski
Journal:  J Am Soc Nephrol       Date:  2018-12-07       Impact factor: 10.121

Review 6.  The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.

Authors:  Jaimee L Heffner; Jeffrey R Strawn; Melissa P DelBello; Stephen M Strakowski; Robert M Anthenelli
Journal:  Bipolar Disord       Date:  2011 Aug-Sep       Impact factor: 6.744

7.  Primary care providers advising smokers to quit: comparing effectiveness between those with and without alcohol, drug, or mental disorders.

Authors:  Michael K Ong; Qiong Zhou; Hai-Yen Sung
Journal:  Nicotine Tob Res       Date:  2011-08-22       Impact factor: 4.244

8.  A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications.

Authors:  Carla A Green; Shannon L Janoff; Bobbi Jo H Yarborough; Micah T Yarborough
Journal:  Community Ment Health J       Date:  2014-02-25

9.  Implementing Effective Policy in a National Mental Health Reengagement Program for Veterans.

Authors:  Shawna N Smith; Zongshan Lai; Daniel Almirall; David E Goodrich; Kristen M Abraham; Kristina M Nord; Amy M Kilbourne
Journal:  J Nerv Ment Dis       Date:  2017-02       Impact factor: 2.254

10.  Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

Authors:  Carmen Moreno; Roberto Nuevo; Somnath Chatterji; Emese Verdes; Celso Arango; José Luis Ayuso-Mateos
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.